Andrea Paccone
- Cardiology and Cardiovascular Medicine top 10%
- Molecular Biology
- Endocrinology, Diabetes and Metabolism top 10%
- Oncology
- Pulmonary and Respiratory Medicine
- Co-authors
- Nicola MaureaMaria Laura CanaleGerardo BottiAntônio BarbieriVincenzo QuagliarielloMichelino De LaurentiisMariarosaria ConteLucia Altucci
- Topics
- Chemotherapy-induced cardiotoxicity and mitigation (25 papers)Peptidase Inhibition and Analysis (12 papers)Cancer Immunotherapy and Biomarkers (8 papers)
- Journals
- CirculationJournal of Clinical OncologySHILAP Revista de lepidopterología
In The Last Decade
Andrea Paccone
48 papers receiving 552 citations
Hit Papers
Peers
Comparison fields: 5 of 73
- Cardiology and Cardiovascular Medicine 272
- Molecular Biology 166
- Endocrinology, Diabetes and Metabolism 130
- Oncology 116
- Pulmonary and Respiratory Medicine 107
Countries citing papers authored by Andrea Paccone
This map shows the geographic impact of Andrea Paccone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Paccone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Paccone more than expected).
Fields of papers citing papers by Andrea Paccone
This network shows the impact of papers produced by Andrea Paccone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Paccone. The network helps show where Andrea Paccone may publish in the future.
Co-authorship network of co-authors of Andrea Paccone
This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Paccone. A scholar is included among the top collaborators of Andrea Paccone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Paccone. Andrea Paccone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 10 | |
| 5 | 1 | |
| 6 | 7 | |
| 7 | 0 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 0 | |
| 11 | 0 | |
| 12 | 1 | |
| 13 | 1 | |
| 14 | 40 | |
| 15 | 1 | |
| 16 | 1 | |
| 17 | The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicinbreakdown → | 268 |
| 18 | 38 | |
| 19 | 6 | |
| 20 | 1 |
About Andrea Paccone
Andrea Paccone is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Internal Medicine, having authored 57 papers that have together received 556 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (25 papers), Peptidase Inhibition and Analysis (12 papers) and Cancer Immunotherapy and Biomarkers (8 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (272 citations), Endocrinology, Diabetes and Metabolism (130 citations) and Oncology (116 citations). Andrea Paccone has collaborated with scholars based in Italy, India and Vietnam. Frequent co-authors include Nicola Maurea, Maria Laura Canale, Gerardo Botti, Antônio Barbieri, Vincenzo Quagliariello, Michelino De Laurentiis, Mariarosaria Conte, Lucia Altucci, Andreina Carbone and Domenica Rea. Their work appears in journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.